Dallas, TX · Founded 2013 · Privately Held (backing)
Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. Osteal Therapeutics is based in Dallas, TX and was founded in 2013. It was valued at $576 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $133 million across 4 recorded rounds; the latest was a $15.6 million early-stage round in Oct 2025.
PMV mark · valuation
$575.6M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$133.1M
Last round
Early Stage VC
Oct 2025
Cap table — not yet on record
Osteal Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Osteal Therapeutics with a free account
·Watch Osteal Therapeutics: the Monday email on marks, rounds and moves
Where does Osteal Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Osteal Therapeutics's 4 recorded funding rounds.
